Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying

7/25/24 9:12:19 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Medical/Dental Instruments

Health Care

Get the next $ATYR alert in real time by email

The Dow Jones index closed lower by over 500 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Super League Enterprise

The Trade: Super League Enterprise, Inc. (NASDAQ:SLE) Director Jeff Patrick Gehl bought a total of 50,000 shares at an average price of $1.35. To acquire these shares, it cost around $67,548.
What's Happening: On June 21, Super League issued a mid-year update from the Company's Chief Executive Office, Ann Hand.
What Super League Enterprise Does: Super League Enterprise Inc is the rocket ship to the metaverse.

aTyr Pharma

The Trade: aTyr Pharma, Inc. (NASDAQ:ATYR) Director Paul Schimmel acquired a total of 100,000 shares at an average price of $1.85. To acquire these shares, it cost around $184,613.
What's Happening: On July 22, HC Wainwright & Co. analyst Joseph Pantginis reiterated aTyr Pharma with a Buy rating and maintained a $35 price target.
What aTyr Pharma Does: aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform.

Retractable Technologies

The Trade: Retractable Technologies, Inc. (NYSE:RVP) President and CEO Thomas J Shaw acquired a total of 8,788 shares at an average price of $1.09. The insider spent around $9,579 to buy those shares.
What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales results.
What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.

Read Next:

Nasdaq, S&P 500 Record Worst Session Since 2022 Amid Tesla, Alphabet Selloff: Investor Optimism Decreases Further

Get the next $ATYR alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ATYR
$RVP
$SLE

Company	Date	Price Target	Rating	Analyst
aTyr Pharma Inc. $ATYR	10/4/2024	$17.00	Overweight	Wells Fargo
aTyr Pharma Inc. $ATYR	9/5/2024	$9.00	Buy	Jefferies

More analyst ratings

$ATYR
$RVP
$SLE
Financials

Live finance-specific insights

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2024 through September 30, 2024. The dividends will be paid on October 21, 2024 to shareholders of record as of the close of business on October 10, 2024. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV
9/30/24 3:46:00 PM ET
$RVP
Medical/Dental Instruments
Health Care
Super League Sets Second Quarter 2024 Earnings Date, August 14, 2024
SANTA MONICA, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Super League (NASDAQ:SLE) (the "Company"), a leader in redefining the gaming industry as a media channel, announced today that the Company will post its second quarter 2024 financial results after market close on Wednesday, August 14, 2024. A webinar will be held the same day at 5:00 pm Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link. Super League Second Quarter 2024 Earnings Webinar Date:Wednesday, August 14, 2024Time:5:00 pm Eastern TimeDial-in:1-877-407-0779International Dial-in:1-201-389-0914Webinar:Register Here A replay will be available shortly after the we
8/1/24 8:00:00 AM ET
$SLE
Services-Misc. Amusement & Recreation
Consumer Discretionary
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2024 through June 30, 2024. The dividends will be paid on July 22, 2024 to shareholders of record as of the close of business on July 10, 2024. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter
6/28/24 1:03:00 PM ET
$RVP
Medical/Dental Instruments
Health Care

Super League Completes Initial Stage of Equity Exchange Transfer with Infinite Reality
~ Appoints Clark Callander to SLE's Board of Directors ~ ~ Significant Steps Taken Towards Transformative Transaction ~ SANTA MONICA, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Super League Enterprise, Inc. (NASDAQ:SLE), a global leader in redefining the gaming industry as a media channel, announced today that Clark Callander has been formally appointed to the Super League Board of Directors, effective October 29th, 2024. Additionally, as an initial step in the previously announced equity exchange transfer, Infinite Reality (iR) has acquired 1,215,279 shares of Super League common stock. The exchange transfer will be finalized following the SLE annual general meeting with iR's owners
10/29/24 4:15:51 PM ET
$SLE
Services-Misc. Amusement & Recreation
Consumer Discretionary
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (NASDAQ:ATYR) ("aTyr" or "the Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced the appointment of Jayant Aphale, Ph.D., as Vice President, Technical Operations. Dr. Aphale will serve as a member of the Company's executive leadership team, overseeing manufacturing activities at contract development and manufacturing organizations and implementing strategies related to the continuous improvement of commercial manufacturing, supply chain management, process development of new products and product lif
8/6/24 8:00:00 AM ET
$ATYR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Embark on an Epic Adventure With the DreamWorks Animation's Trolls Band Together Experience on Roblox's Livetopia
SANTA MONICA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Prepare to be transported into a world of colorful wonder and musical magic as DreamWorks Animation's new chapter in its blockbuster musical franchise, Trolls Band Together, makes its grand entrance on Roblox in the Livetopia Trolls Band Together Experience brought to life by Super League (NASDAQ:SLE), a leading publisher of immersive experiences across the world's largest metaverse gaming platforms. DreamWorks Animation's Trolls Band Together arrives in sneak previews Nov. 4 and in theaters Nov. 17. This unprecedented collaboration kicks off with five weeks of non-stop excitement, including an exclusive Trolls listening pa
10/19/23 8:00:00 AM ET
$SLE
Services-Misc. Amusement & Recreation
Consumer Discretionary

$ATYR
$RVP
$SLE
Press Releases

Fastest customizable press release news feed in the world

HI-CHEW® Returns to Fortnite With Limited-Time Games, Collectibles and New Mascot, Chewbie
SANTA MONICA, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HI-CHEW®, the immensely fruity, intensely chewy candy, today announced a new immersive integration with the hugely popular game Fortnite. Building on HI-CHEW's successful Fortnite integration last year, this new collaboration is again powered by Super League (NASDAQ:SLE), a global leader in delivering immersive experiences across the world's largest gaming platforms. HI-CHEW® branded customizations will be integrated into two of Fortnite's Minigame Box PVP Island mini-games: Color Switch and Spin Cycle, in addition to HI-CHEW® Hoppers, a new custom minigame. Players can collect HI-CHEW® branded power-ups and in-game currency that can
11/18/24 9:00:00 AM ET
$SLE
Services-Misc. Amusement & Recreation
Consumer Discretionary
aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis
SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (NASDAQ:ATYR) ("aTyr" or the "Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Company will present two posters related to its tRNA synthetase candidate ATYR0101 at the Keystone Symposia on Fibrosis: Inflammation, Drivers, and Therapeutic Resolution, which is scheduled to take place December 8 – 11, 2024, in Whistler, British Columbia, Canada. Details of the presentations appear below. The posters will be available on the aTyr website once presented. Title: A Newly Evolved Domai
11/15/24 8:00:00 AM ET
$ATYR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024
Retractable Technologies, Inc. (NYSE:RVP) reports total net sales of $10.3 million for the third quarter of 2024 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $10.3 million and an operating loss of $936 thousand. For the first nine months of the year, net sales were $24.0 million and operating losses were $13.9 million as compared to 2023 net revenues of $29.3 million and operating losses of $8.7 million. The decline in gross profit in the third quarter of 2024 was primarily due to a decrease in the average selling price, a drop in international sales, and rising production costs. The decline in international sales had
11/14/24 5:16:00 PM ET
$RVP
Medical/Dental Instruments
Health Care